{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:35:38Z","timestamp":1793111738126,"version":"4.5.0"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00125-026-06838-8","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:01:36Z","timestamp":1790049696000},"page":"3409-3424","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An international position statement on practical approaches for inpatient continuous glucose monitoring, insulin pumps and automated insulin delivery systems in adults"],"prefix":"10.1007","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2474-6168","authenticated-orcid":false,"given":"Mikkel T.","family":"Olsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9352-7172","authenticated-orcid":false,"given":"Elias K.","family":"Spanakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6076-6997","authenticated-orcid":false,"given":"Hood","family":"Thabit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3619-9579","authenticated-orcid":false,"given":"Ketan","family":"Dhatariya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3123-809X","authenticated-orcid":false,"given":"Omar G.","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9047-3589","authenticated-orcid":false,"given":"Parizad","family":"Avari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7041-9534","authenticated-orcid":false,"given":"Alistair N.","family":"Lumb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1289-1595","authenticated-orcid":false,"given":"Katheleen","family":"Dungan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3986-9630","authenticated-orcid":false,"given":"Athena","family":"Philis-Tsimikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3559-5046","authenticated-orcid":false,"given":"Kristen","family":"Kulasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0870-4032","authenticated-orcid":false,"given":"David N.","family":"O\u2019Neal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0990-5821","authenticated-orcid":false,"given":"Shashank R.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1713-3064","authenticated-orcid":false,"given":"Alexandros L.","family":"Liarakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8698-6207","authenticated-orcid":false,"given":"Emma G.","family":"Wilmot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9416-787X","authenticated-orcid":false,"given":"Julie L. V.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3523-669X","authenticated-orcid":false,"given":"Roman","family":"Vangoitsenhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6099-2406","authenticated-orcid":false,"given":"Chantal","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1675-8417","authenticated-orcid":false,"given":"Irl B.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyathama","family":"Vellanki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3845-6703","authenticated-orcid":false,"given":"Francisco J.","family":"Pasquel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3252-5026","authenticated-orcid":false,"given":"Guillermo","family":"Umpierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9295-3225","authenticated-orcid":false,"given":"Rodolfo J.","family":"Galindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0588-4880","authenticated-orcid":false,"given":"Ulrik","family":"Pedersen-Bjergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5431-824X","authenticated-orcid":false,"given":"Peter L.","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7854-4233","authenticated-orcid":false,"given":"Julia K.","family":"Mader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1620-8271","authenticated-orcid":false,"given":"Kirsten","family":"N\u00f8rgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"6838_CR1","doi-asserted-by":"publisher","first-page":"569","DOI":"10.2337\/dc24-2222","volume":"48","author":"MT Olsen","year":"2025","unstructured":"Olsen MT, Klarskov CK, Jensen SH et al (2025) In-hospital diabetes management by a diabetes team and insulin titration algorithms based on continuous glucose monitoring or point-of-care glucose testing in patients with type 2 diabetes (DIATEC): a randomized controlled trial. Diabetes Care 48:569\u2013578. https:\/\/doi.org\/10.2337\/dc24-2222","journal-title":"Diabetes Care"},{"key":"6838_CR2","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.2337\/dc22-0716","volume":"45","author":"EK Spanakis","year":"2022","unstructured":"Spanakis EK, Urrutia A, Galindo RJ et al (2022) Continuous glucose monitoring-guided insulin administration in hospitalized patients with diabetes: a randomized clinical trial. Diabetes Care 45:2369\u20132375. https:\/\/doi.org\/10.2337\/dc22-0716","journal-title":"Diabetes Care"},{"key":"6838_CR3","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.2337\/dc20-0840","volume":"43","author":"LG Singh","year":"2020","unstructured":"Singh LG, Satyarengga M, Marcano I et al (2020) Reducing inpatient hypoglycemia in the general wards using real-time continuous glucose monitoring: the glucose telemetry system, a randomized clinical trial. Diabetes Care 43:2736\u20132743. https:\/\/doi.org\/10.2337\/dc20-0840","journal-title":"Diabetes Care"},{"key":"6838_CR4","doi-asserted-by":"publisher","first-page":"111986","DOI":"10.1016\/j.diabres.2024.111986","volume":"220","author":"GC Lima Chagas","year":"2025","unstructured":"Lima Chagas GC, Teixeira L, Clemente MRC et al (2025) Use of continuous glucose monitoring and point-of-care glucose testing in hospitalized patients with diabetes mellitus in non-intensive care unit settings: a systematic review and meta-analysis of randomized controlled trials. Diabetes Res Clin Pract 220:111986. https:\/\/doi.org\/10.1016\/j.diabres.2024.111986","journal-title":"Diabetes Res Clin Pract"},{"key":"6838_CR5","doi-asserted-by":"publisher","first-page":"bvaf137","DOI":"10.1210\/jendso\/bvaf137","volume":"9","author":"MT Olsen","year":"2025","unstructured":"Olsen MT, Jensen SH, Rasmussen LM et al (2025) Glycemic levels and insulin use daily and during hospital shifts in hospitalized patients with type 2 diabetes. J Endocr Soc 9:bvaf137. https:\/\/doi.org\/10.1210\/jendso\/bvaf137","journal-title":"J Endocr Soc"},{"key":"6838_CR6","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1210\/jcem.87.3.8341","volume":"87","author":"GE Umpierrez","year":"2002","unstructured":"Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE (2002) Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 87:978\u2013982. https:\/\/doi.org\/10.1210\/jcem.87.3.8341","journal-title":"J Clin Endocrinol Metab"},{"key":"6838_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12890-022-01874-7","volume":"22","author":"MT Olsen","year":"2022","unstructured":"Olsen MT, Dungu AM, Klarskov CK, Jensen AK, Lindegaard B, Kristensen PL (2022) Glycemic variability assessed by continuous glucose monitoring in hospitalized patients with community-acquired pneumonia. BMC Pulm Med 22:83. https:\/\/doi.org\/10.1186\/s12890-022-01874-7","journal-title":"BMC Pulm Med"},{"key":"6838_CR8","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1136\/thx.2005.051029","volume":"61","author":"EH Baker","year":"2006","unstructured":"Baker EH, Janaway CH, Philips BJ et al (2006) Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax 61:284\u2013289. https:\/\/doi.org\/10.1136\/thx.2005.051029","journal-title":"Thorax"},{"key":"6838_CR9","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00592-024-02370-6","volume":"62","author":"O Sim\u00f3-Servat","year":"2025","unstructured":"Sim\u00f3-Servat O, Amig\u00f3 J, Ortiz-Z\u00fa\u00f1iga \u00c1 et al (2025) Smart diabetes hospital: clinical impact in complex surgical units of a tertiary hospital. Acta Diabetol 62:423\u2013428. https:\/\/doi.org\/10.1007\/s00592-024-02370-6","journal-title":"Acta Diabetol"},{"key":"6838_CR10","doi-asserted-by":"publisher","first-page":"948","DOI":"10.2337\/dc23-1905","volume":"47","author":"RD Barmanray","year":"2024","unstructured":"Barmanray RD, Kyi M, Colman PG et al (2024) The Specialist Treatment of Inpatients: Caring for Diabetes in Surgery (STOIC-D Surgery) trial: a randomized controlled trial of early intervention with an electronic specialist-led model of diabetes care. Diabetes Care 47:948\u2013955. https:\/\/doi.org\/10.2337\/dc23-1905","journal-title":"Diabetes Care"},{"key":"6838_CR11","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.2337\/dci18-0002","volume":"41","author":"GE Umpierrez","year":"2018","unstructured":"Umpierrez GE, Klonoff DC (2018) Diabetes technology update: use of insulin pumps and continuous glucose monitoring in the hospital. Diabetes Care 41:1579\u20131589. https:\/\/doi.org\/10.2337\/dci18-0002","journal-title":"Diabetes Care"},{"key":"6838_CR12","doi-asserted-by":"publisher","unstructured":"Avari P, Lumb A, Flanagan D et al (2023) Continuous glucose monitoring within hospital: a scoping review and summary of guidelines from the Joint British Diabetes Societies for Inpatient Care. J Diabetes Sci Technol 17:611\u2013624. https:\/\/doi.org\/10.1177\/19322968221137338","DOI":"10.1177\/19322968221137338"},{"key":"6838_CR13","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1177\/19322968231161076","volume":"17","author":"A Lumb","year":"2023","unstructured":"Lumb A, Misra S, Rayman G et al (2023) Variation in the current use of technology to support diabetes management in UK hospitals: results of a survey of health care professionals. J Diabetes Sci Technol 17:733\u2013741. https:\/\/doi.org\/10.1177\/19322968231161076","journal-title":"J Diabetes Sci Technol"},{"key":"6838_CR14","doi-asserted-by":"publisher","unstructured":"Irace C, Coluzzi S, Di Cianni G et al (2023) Continuous glucose monitoring (CGM) in a non-ICU hospital setting: the patient\u2019s journey. Nutr Metab Cardiovasc Dis 33:2107\u20132118. https:\/\/doi.org\/10.1016\/j.numecd.2023.06.021","DOI":"10.1016\/j.numecd.2023.06.021"},{"key":"6838_CR15","doi-asserted-by":"publisher","first-page":"e14573","DOI":"10.1111\/dme.14573","volume":"38","author":"F Akiboye","year":"2021","unstructured":"Akiboye F, Sihre HK, Al Mulhem M, Rayman G, Nirantharakumar K, Adderley NJ (2021) Impact of diabetes specialist nurses on inpatient care: a systematic review. Diabet Med 38:e14573. https:\/\/doi.org\/10.1111\/dme.14573","journal-title":"Diabet Med"},{"key":"6838_CR16","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1177\/1932296821993169","volume":"15","author":"CK Klarskov","year":"2021","unstructured":"Klarskov CK, Kristensen PL (2021) Experience from implementing telemetric in-hospital continuous glucose monitoring during the COVID-19 pandemic. J Diabetes Sci Technol 15:715\u2013716. https:\/\/doi.org\/10.1177\/1932296821993169","journal-title":"J Diabetes Sci Technol"},{"key":"6838_CR17","doi-asserted-by":"publisher","unstructured":"Wallia A, Umpierrez GE, Rushakoff RJ et al.; DTS Continuous Glucose Monitoring in the Hospital Panel (2017) Consensus statement on inpatient use of continuous glucose monitoring. J Diabetes Sci Technol 11:1036\u20131044. https:\/\/doi.org\/10.1177\/1932296817706151","DOI":"10.1177\/1932296817706151"},{"key":"6838_CR18","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.1210\/jc.2016-2534","volume":"101","author":"AL Peters","year":"2016","unstructured":"Peters AL, Ahmann AJ, Battelino T et al (2016) Diabetes technology-continuous subcutaneous insulin infusion therapy and continuous glucose monitoring in adults: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 101:3922\u20133937. https:\/\/doi.org\/10.1210\/jc.2016-2534","journal-title":"J Clin Endocrinol Metab"},{"key":"6838_CR19","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1177\/19322968231191104","volume":"17","author":"EK Spanakis","year":"2023","unstructured":"Spanakis EK, Cook CB, Kulasa K et al (2023) A consensus statement for continuous glucose monitoring metrics for inpatient clinical trials. J Diabetes Sci Technol 17:1527\u20131552. https:\/\/doi.org\/10.1177\/19322968231191104","journal-title":"J Diabetes Sci Technol"},{"issue":"Suppl. 1","key":"6838_CR20","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.2337\/dc26-SINT","volume":"49","author":"American Diabetes Association Professional Practice Committee for Diabetes","year":"2026","unstructured":"American Diabetes Association Professional Practice Committee for Diabetes (2026) Introduction and methodology: Standards of Care in Diabetes\u20142026. Diabetes Care 49(Suppl. 1):S1\u2013S5. https:\/\/doi.org\/10.2337\/dc26-SINT","journal-title":"Diabetes Care"},{"key":"6838_CR21","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/dme.14115","volume":"36","author":"A Lake","year":"2019","unstructured":"Lake A, Arthur A, Byrne C, Davenport K, Yamamoto JM, Murphy HR (2019) The effect of hypoglycaemia during hospital admission on health-related outcomes for people with diabetes: a systematic review and meta-analysis. Diabet Med 36:1349\u20131359. https:\/\/doi.org\/10.1111\/dme.14115","journal-title":"Diabet Med"},{"key":"6838_CR22","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1177\/1932296820954163","volume":"14","author":"RJ Galindo","year":"2020","unstructured":"Galindo RJ, Umpierrez GE, Rushakoff RJ et al (2020) Continuous glucose monitors and automated insulin dosing systems in the hospital consensus guideline. J Diabetes Sci Technol 14:1035\u20131064. https:\/\/doi.org\/10.1177\/1932296820954163","journal-title":"J Diabetes Sci Technol"},{"key":"6838_CR23","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.2337\/dci24-0073","volume":"47","author":"JLV Shaw","year":"2024","unstructured":"Shaw JLV, Bannuru RR, Beach L et al (2024) Consensus considerations and good practice points for use of continuous glucose monitoring systems in hospital settings. Diabetes Care 47:2062\u20132075. https:\/\/doi.org\/10.2337\/dci24-0073","journal-title":"Diabetes Care"},{"key":"6838_CR24","doi-asserted-by":"publisher","first-page":"655","DOI":"10.2337\/dc24-2510","volume":"48","author":"LM Wilson","year":"2025","unstructured":"Wilson LM, Herzig SJ, Marcantonio ER et al (2025) Management of diabetes and hyperglycemia in the hospital: a systematic review of clinical practice guidelines. Diabetes Care 48:655\u2013664. https:\/\/doi.org\/10.2337\/dc24-2510","journal-title":"Diabetes Care"},{"key":"6838_CR25","doi-asserted-by":"publisher","first-page":"118","DOI":"10.2337\/dc24-1779","volume":"48","author":"IB Hirsch","year":"2025","unstructured":"Hirsch IB, Draznin B, Buse JB et al (2025) Results from a randomized trial of intensive glucose management using CGM versus usual care in hospitalized adults with type 2 diabetes: the TIGHT study. Diabetes Care 48:118\u2013124. https:\/\/doi.org\/10.2337\/dc24-1779","journal-title":"Diabetes Care"},{"key":"6838_CR26","doi-asserted-by":"publisher","first-page":"5483","DOI":"10.1111\/dom.15885","volume":"26","author":"H Thabit","year":"2024","unstructured":"Thabit H, Rubio J, Karuppan M et al (2024) Use of real-time continuous glucose monitoring in non-critical care insulin-treated inpatients under non-diabetes speciality teams in hospital: a pilot randomized controlled study. Diabetes Obes Metab 26:5483\u20135487. https:\/\/doi.org\/10.1111\/dom.15885","journal-title":"Diabetes Obes Metab"},{"key":"6838_CR27","doi-asserted-by":"publisher","first-page":"e70114","DOI":"10.1111\/dme.70114","volume":"42","author":"MT Olsen","year":"2025","unstructured":"Olsen MT, Vikner ME, Jensen SH et al (2025) Satisfaction with continuous glucose monitoring and diabetes care among hospitalised patients with type 2 diabetes managed by inpatient diabetes teams. Diabet Med 42:e70114. https:\/\/doi.org\/10.1111\/dme.70114","journal-title":"Diabet Med"},{"key":"6838_CR28","doi-asserted-by":"publisher","first-page":"e2411","DOI":"10.1210\/clinem\/dgaf074","volume":"110","author":"MT Olsen","year":"2025","unstructured":"Olsen MT, Liarakos AL, Wilmot EG et al (2025) Implementation strategies for inpatient continuous glucose monitoring-based diabetes management: a systematic review. J Clin Endocrinol Metab 110:e2411\u2013e2419. https:\/\/doi.org\/10.1210\/clinem\/dgaf074","journal-title":"J Clin Endocrinol Metab"},{"key":"6838_CR29","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s11892-024-01549-z","volume":"24","author":"A Philis-Tsimikas","year":"2024","unstructured":"Philis-Tsimikas A, San Diego ERN, Vincent L, Lohnes S, Singleton C (2024) Are we ready for real-time continuous glucose monitoring in the hospital setting? Benefits, challenges, and practical approaches for implementation: case vignette: remote real-time continuous glucose monitoring for hospitalized care in Quincy Koala. Curr Diab Rep 24:217\u2013226. https:\/\/doi.org\/10.1007\/s11892-024-01549-z","journal-title":"Curr Diab Rep"},{"key":"6838_CR30","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1111\/dom.16297","volume":"27","author":"MT Olsen","year":"2025","unstructured":"Olsen MT, Jensen SH, Rasmussen LM et al (2025) Most hospitalised patients with type 2 diabetes benefit from continuous glucose monitoring compared to point-of-care glucose testing in a non-intensive care unit setting: a heterogeneity of treatment effect analysis. Diabetes Obes Metab 27:2857\u20132863. https:\/\/doi.org\/10.1111\/dom.16297","journal-title":"Diabetes Obes Metab"},{"key":"6838_CR31","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.diabet.2016.12.009","volume":"43","author":"W Gu","year":"2017","unstructured":"Gu W, Liu Y, Chen Y et al (2017) Multicentre randomized controlled trial with sensor-augmented pump vs multiple daily injections in hospitalized patients with type 2 diabetes in China: time to reach target glucose. Diabetes Metab 43:359\u2013363. https:\/\/doi.org\/10.1016\/j.diabet.2016.12.009","journal-title":"Diabetes Metab"},{"key":"6838_CR32","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1089\/dia.2023.0304","volume":"25","author":"GM Davis","year":"2023","unstructured":"Davis GM, Hughes MS, Brown SA et al (2023) automated insulin delivery with remote real-time continuous glucose monitoring for hospitalized patients with diabetes: a multicenter, single-arm, feasibility trial. Diabetes Technol Ther 25:677\u2013688. https:\/\/doi.org\/10.1089\/dia.2023.0304","journal-title":"Diabetes Technol Ther"},{"key":"6838_CR33","doi-asserted-by":"publisher","first-page":"e15092","DOI":"10.1111\/dme.15092","volume":"40","author":"CK Boughton","year":"2023","unstructured":"Boughton CK, Hartnell S, Hobday N et al (2023) Implementation of fully closed-loop insulin delivery for inpatients with diabetes: real-world outcomes. Diabet Med 40:e15092. https:\/\/doi.org\/10.1111\/dme.15092","journal-title":"Diabet Med"},{"key":"6838_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.eprac.2022.11.006","volume":"29","author":"MN Pelkey","year":"2023","unstructured":"Pelkey MN, Boyle ME, Long A, Castro JC, Cook CB, Thompson B (2023) Hybrid closed-loop insulin pump technology can be safely used in the inpatient setting. Endocr Pract 29:24\u201328. https:\/\/doi.org\/10.1016\/j.eprac.2022.11.006","journal-title":"Endocr Pract"},{"key":"6838_CR35","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.eprac.2024.07.012","volume":"30","author":"B Thompson","year":"2024","unstructured":"Thompson B, Boyle ME, Castro JC, Dodoo C, Cook CB (2024) Automated insulin delivery technology in the hospital: update on safety and efficacy data. Endocr Pract 30:957\u2013962. https:\/\/doi.org\/10.1016\/j.eprac.2024.07.012","journal-title":"Endocr Pract"},{"key":"6838_CR36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S2213-8587(16)30280-7","volume":"5","author":"H Thabit","year":"2017","unstructured":"Thabit H, Hartnell S, Allen JM et al (2017) Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial. Lancet Diabetes Endocrinol 5:117\u2013124. https:\/\/doi.org\/10.1016\/S2213-8587(16)30280-7","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6838_CR37","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1056\/NEJMoa1805233","volume":"379","author":"L Bally","year":"2018","unstructured":"Bally L, Thabit H, Hartnell S et al (2018) Closed-loop insulin delivery for glycemic control in noncritical care. N Engl J Med 379:547\u2013556. https:\/\/doi.org\/10.1056\/NEJMoa1805233","journal-title":"N Engl J Med"},{"key":"6838_CR38","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S2213-8587(19)30061-0","volume":"7","author":"CK Boughton","year":"2019","unstructured":"Boughton CK, Bally L, Martignoni F et al (2019) Fully closed-loop insulin delivery in inpatients receiving nutritional support: a two-centre, open-label, randomised controlled trial. Lancet Diabetes Endocrinol 7:368\u2013377. https:\/\/doi.org\/10.1016\/S2213-8587(19)30061-0","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6838_CR39","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/19322968251323614","volume":"20","author":"K Benhalima","year":"2026","unstructured":"Benhalima K, Polsky S (2026) Automated insulin delivery in pregnancies complicated by type 1 diabetes. J Diabetes Sci Technol 20:38\u201349. https:\/\/doi.org\/10.1177\/19322968251323614","journal-title":"J Diabetes Sci Technol"},{"key":"6838_CR40","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1007\/s00125-024-06206-4","volume":"67","author":"H Thabit","year":"2024","unstructured":"Thabit H, Schofield J (2024) Technology in the management of diabetes in hospitalised adults. Diabetologia 67:2114\u20132128. https:\/\/doi.org\/10.1007\/s00125-024-06206-4","journal-title":"Diabetologia"},{"key":"6838_CR41","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1177\/1932296818769933","volume":"12","author":"B Thompson","year":"2018","unstructured":"Thompson B, Korytkowski M, Klonoff DC, Cook CB (2018) Consensus statement on use of continuous subcutaneous insulin infusion therapy in the hospital. J Diabetes Sci Technol 12:880\u2013889. https:\/\/doi.org\/10.1177\/1932296818769933","journal-title":"J Diabetes Sci Technol"},{"key":"6838_CR42","doi-asserted-by":"publisher","first-page":"108803","DOI":"10.1016\/j.jdiacomp.2024.108803","volume":"38","author":"MT Olsen","year":"2024","unstructured":"Olsen MT, Klarskov CK, Hansen KB, Pedersen-Bjergaard U, Kristensen PL (2024) Risk factors at admission of in-hospital dysglycemia, mortality, and readmissions in patients with type 2 diabetes and pneumonia. J Diabetes Complications 38:108803. https:\/\/doi.org\/10.1016\/j.jdiacomp.2024.108803","journal-title":"J Diabetes Complications"},{"key":"6838_CR43","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1177\/1932296820918540","volume":"14","author":"P Cruz","year":"2020","unstructured":"Cruz P (2020) Inpatient hypoglycemia: the challenge remains. J Diabetes Sci Technol 14:560\u2013566. https:\/\/doi.org\/10.1177\/1932296820918540","journal-title":"J Diabetes Sci Technol"},{"key":"6838_CR44","doi-asserted-by":"publisher","first-page":"e03913","DOI":"10.1016\/j.heliyon.2020.e03913","volume":"6","author":"C Pratiwi","year":"2020","unstructured":"Pratiwi C, Mokoagow MI, Made Kshanti IA, Soewondo P (2020) The risk factors of inpatient hypoglycemia: a systematic review. Heliyon 6:e03913. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e03913","journal-title":"Heliyon"},{"key":"6838_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/EP-2019-0607","volume":"26","author":"GE Umpierrez","year":"2020","unstructured":"Umpierrez GE, Holt EH, Einhorn D, McGill JB (2020) Concentrated insulins: clinical update of therapeutic options. Endocr Pract 26:1\u201312. https:\/\/doi.org\/10.4158\/EP-2019-0607","journal-title":"Endocr Pract"},{"key":"6838_CR46","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s13300-022-01342-9","volume":"14","author":"SW Wei","year":"2023","unstructured":"Wei SW, Jiang SQ (2023) Risk factors for glycemic control in hospitalized patients with type 2 diabetes receiving continuous subcutaneous insulin infusion therapy. Diabetes Therapy 14:167\u2013178. https:\/\/doi.org\/10.1007\/s13300-022-01342-9","journal-title":"Diabetes Therapy"},{"key":"6838_CR47","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2337\/dc16-0989","volume":"40","author":"FJ Pasquel","year":"2017","unstructured":"Pasquel FJ, Umpierrez GE (2017) Management of inpatient hyperglycemia and diabetes in older adults. Diabetes Care 40:509\u2013517. https:\/\/doi.org\/10.2337\/dc16-0989","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"6838_CR48","doi-asserted-by":"publisher","first-page":"S277","DOI":"10.2337\/dc26-S013","volume":"49","author":"American Diabetes Association Professional Practice Committee for Diabetes","year":"2026","unstructured":"American Diabetes Association Professional Practice Committee for Diabetes (2026) 13. Older adults: standards of care in diabetes\u20142026. Diabetes Care 49(Suppl 1):S277\u2013S296. https:\/\/doi.org\/10.2337\/dc26-S013","journal-title":"Diabetes Care"},{"key":"6838_CR49","doi-asserted-by":"publisher","first-page":"e70321","DOI":"10.1111\/dme.70321","volume":"43","author":"MT Olsen","year":"2026","unstructured":"Olsen MT, N\u00f8rgaard K, Jensen SH et al (2026) Acute kidney injury in hospitalised patients with type 2 diabetes: associations with continuous glucose monitoring-based glucose levels, mortality, and ICU admission. Diabet Med 43:e70321. https:\/\/doi.org\/10.1111\/dme.70321","journal-title":"Diabet Med"},{"key":"6838_CR50","doi-asserted-by":"publisher","unstructured":"Avari P, Lumb A, Flanagan D et al (2023) Insulin pumps and hybrid close loop systems within hospital: a scoping review and practical guidance from the joint British diabetes societies for inpatient care. J Diabetes Sci Technol 17:625\u2013634. https:\/\/doi.org\/10.1177\/19322968221137335","DOI":"10.1177\/19322968221137335"},{"key":"6838_CR51","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.2337\/dc20-1016","volume":"43","author":"AL Fortmann","year":"2020","unstructured":"Fortmann AL, Bagsic SRS, Talavera L et al (2020) Glucose as the fifth vital sign: a randomized controlled trial of continuous glucose monitoring in a non-ICU hospital setting. Diabetes Care 43:2873\u20132877. https:\/\/doi.org\/10.2337\/dc20-1016","journal-title":"Diabetes Care"},{"key":"6838_CR52","doi-asserted-by":"publisher","first-page":"100109","DOI":"10.1016\/j.chstcc.2024.100109","volume":"3","author":"NL Haas","year":"2025","unstructured":"Haas NL, Ang L, Esfandiari NH et al (2025) Analytical accuracy of a continuous glucose monitor in adult diabetic ketoacidosis. CHEST Critical Care 3:100109. https:\/\/doi.org\/10.1016\/j.chstcc.2024.100109","journal-title":"CHEST Critical Care"},{"key":"6838_CR53","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"Battelino T, Danne T, Bergenstal RM et al (2019) Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care 42:1593\u20131603. https:\/\/doi.org\/10.2337\/dci19-0028","journal-title":"Diabetes Care"},{"key":"6838_CR54","doi-asserted-by":"publisher","DOI":"10.1177\/19322968251331628","author":"MT Olsen","year":"2025","unstructured":"Olsen MT, Hansen KB, Pedersen-Bjergaard U, Kristensen PL (2025) Time at high risk of hypoglycemia \u2013 validation of a consensus-based continuous glucose monitoring-metric for hospitalized patients. J Diabetes Sci Technol. https:\/\/doi.org\/10.1177\/19322968251331628","journal-title":"J Diabetes Sci Technol"},{"key":"6838_CR55","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1177\/1932296813520367","volume":"8","author":"JH Flory","year":"2014","unstructured":"Flory JH, Aleman JO, Furst J, Seley JJ (2014) Basal insulin use in the non-critical care setting. J Diabetes Sci Technol 8:427\u2013428. https:\/\/doi.org\/10.1177\/1932296813520367","journal-title":"J Diabetes Sci Technol"},{"key":"6838_CR56","doi-asserted-by":"publisher","unstructured":"Olsen MT, Klarskov CK, Bjergaard UP, Hansen KB, Kristensen PL (2024) Summary of clinical investigation plan for The DIATEC trial: in-hospital diabetes management by a diabetes team and continuous glucose monitoring or point of care glucose testing \u2013 a randomised controlled trial. BMC Endocr Disord 24(1):60. https:\/\/doi.org\/10.1186\/s12902-024-01595-4","DOI":"10.1186\/s12902-024-01595-4"},{"key":"6838_CR57","doi-asserted-by":"publisher","unstructured":"Olsen MT, Pedersen-Bjergaard U, Jensen SH, Rasmussen LM, Klarskov CK (2025) Evaluation of a continuous glucose monitoring-based insulin titration protocol for inpatients with type 2 diabetes in nonintensive care unit settings. J Diabetes Sci Technol 19322968251331628. https:\/\/doi.org\/10.1177\/19322968251331628","DOI":"10.1177\/19322968251331628"},{"key":"6838_CR58","unstructured":"US Food and Drug Administration (2022) Medical devices; clinical chemistry and clinical toxicology devices; classification of the integrated continuous glucose monitoring system. 21 CFR Part 862. Fed Regist 87:9237\u20139239.\u00a0www.federalregister.gov\/documents\/2022\/02\/18\/2022-03504\/medical-devices-clinical-chemistry-and-clinical-toxicology-devices-classification-of-the-integrated. Accessed 12 Jan 2026"},{"key":"6838_CR59","doi-asserted-by":"publisher","first-page":"S321","DOI":"10.2337\/dc25-S016","volume":"48","author":"American Diabetes Association Professional Practice Committee for Diabetes","year":"2025","unstructured":"American Diabetes Association Professional Practice Committee for Diabetes (2025) 16. Diabetes care in the hospital: standards of care in diabetes\u20142025. Diabetes Care 48:S321\u2013S334. https:\/\/doi.org\/10.2337\/dc25-S016","journal-title":"Diabetes Care"},{"key":"6838_CR60","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/EJA.0000000000002095","volume":"42","author":"A Putzu","year":"2025","unstructured":"Putzu A, Grange E, Schorer R, Schiffer E, Gariani K (2025) Continuous peri-operative glucose monitoring in noncardiac surgery. Eur J Anaesthesiol 42:162\u2013171. https:\/\/doi.org\/10.1097\/EJA.0000000000002095","journal-title":"Eur J Anaesthesiol"},{"key":"6838_CR61","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1213\/ANE.0000000000007115","volume":"140","author":"P Cruz","year":"2025","unstructured":"Cruz P, McKee AM, Chiang H-H et al (2025) Perioperative care of patients using wearable diabetes devices. Anesth Analg 140:2\u201312. https:\/\/doi.org\/10.1213\/ANE.0000000000007115","journal-title":"Anesth Analg"},{"key":"6838_CR62","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1213\/ANE.0000000000004491","volume":"130","author":"LD Martin","year":"2020","unstructured":"Martin LD, Hoagland MA, Rhodes ET, Wolfsdorf JI, Hamrick JL (2020) Perioperative management of pediatric patients with type 1 diabetes mellitus, updated recommendations for anesthesiologists. Anesth Analg 130:821\u2013827. https:\/\/doi.org\/10.1213\/ANE.0000000000004491","journal-title":"Anesth Analg"},{"key":"6838_CR63","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13741-023-00302-6","volume":"12","author":"R Sreedharan","year":"2023","unstructured":"Sreedharan R, Khanna S, Shaw A (2023) Perioperative glycemic management in adults presenting for elective cardiac and non-cardiac surgery. Perioper Med 12:13. https:\/\/doi.org\/10.1186\/s13741-023-00302-6","journal-title":"Perioper Med"},{"key":"6838_CR64","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/bja\/aev347","volume":"116","author":"H Partridge","year":"2016","unstructured":"Partridge H, Perkins B, Mathieu S, Nicholls A, Adeniji K (2016) Clinical recommendations in the management of the patient with type 1 diabetes on insulin pump therapy in the perioperative period: a primer for the anaesthetist. Br J Anaesth 116:18\u201326. https:\/\/doi.org\/10.1093\/bja\/aev347","journal-title":"Br J Anaesth"},{"key":"6838_CR65","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1213\/ANE.0000000000006791","volume":"139","author":"N Rajan","year":"2024","unstructured":"Rajan N, Duggan EW, Abdelmalak BB et al (2024) Society for ambulatory anesthesia updated consensus statement on perioperative blood glucose management in adult patients with diabetes mellitus undergoing ambulatory surgery. Anesth Analg 139:459\u2013477. https:\/\/doi.org\/10.1213\/ANE.0000000000006791","journal-title":"Anesth Analg"},{"key":"6838_CR66","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11892-021-01375-7","volume":"21","author":"T Yeh","year":"2021","unstructured":"Yeh T, Yeung M, Mendelsohn Curanaj FA (2021) Managing patients with insulin pumps and continuous glucose monitors in the hospital: to wear or not to wear. Curr Diab Rep 21:7. https:\/\/doi.org\/10.1007\/s11892-021-01375-7","journal-title":"Curr Diab Rep"},{"key":"6838_CR67","doi-asserted-by":"crossref","unstructured":"Lal S, Khan E (2024) Perioperative management of diabetic patients: optimising care with insulin pumps and CGM devices. Available from: https:\/\/resources.wfsahq.org\/wp-content\/uploads\/ATOTW_524.pdf. Accessed 12 Jan 2026","DOI":"10.28923\/atotw.524"},{"key":"6838_CR68","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.4158\/EP15727.OR","volume":"21","author":"SI Sobel","year":"2015","unstructured":"Sobel SI, Augustine M, Donihi AC, Reider J, Forte P, Korytkowski M (2015) Safety and efficacy of a peri-operative protocol for patients with diabetes treated with continuous subcutaneous insulin infusion who are admitted for same-day surgery. Endocr Pract 21:1269\u20131276. https:\/\/doi.org\/10.4158\/EP15727.OR","journal-title":"Endocr Pract"},{"key":"6838_CR69","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1177\/193229681200600503","volume":"6","author":"SM Corney","year":"2012","unstructured":"Corney SM, Dukatz T, Rosenblatt S et al (2012) Comparison of insulin pump therapy (Continuous Subcutaneous Insulin Infusion) to alternative methods for perioperative glycemic management in patients with planned postoperative admissions. J Diabetes Sci Technol 6:1003\u20131015. https:\/\/doi.org\/10.1177\/193229681200600503","journal-title":"J Diabetes Sci Technol"},{"key":"6838_CR70","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1177\/1932296814522809","volume":"8","author":"S Kannan","year":"2014","unstructured":"Kannan S, Satra A, Calogeras E, Lock P, Lansang MC (2014) Insulin pump patient characteristics and glucose control in the hospitalized setting. J Diabetes Sci Technol 8:473\u2013478. https:\/\/doi.org\/10.1177\/1932296814522809","journal-title":"J Diabetes Sci Technol"},{"key":"6838_CR71","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1177\/193229681200600504","volume":"6","author":"ME Boyle","year":"2012","unstructured":"Boyle ME, Seifert KM, Beer KA et al (2012) Insulin pump therapy in the perioperative period: a review of care after implementation of institutional guidelines. J Diabetes Sci Technol 6:1016\u20131021. https:\/\/doi.org\/10.1177\/193229681200600504","journal-title":"J Diabetes Sci Technol"},{"key":"6838_CR72","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1177\/1932296815592027","volume":"9","author":"PA Mackey","year":"2015","unstructured":"Mackey PA, Thompson BM, Boyle ME et al (2015) Update on a quality initiative to standardize perioperative care for continuous subcutaneous insulin infusion therapy. J Diabetes Sci Technol 9:1299\u20131306. https:\/\/doi.org\/10.1177\/1932296815592027","journal-title":"J Diabetes Sci Technol"},{"key":"6838_CR73","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1213\/ANE.0000000000003779","volume":"128","author":"MT Long","year":"2019","unstructured":"Long MT, Coursin DB, Rice MJ (2019) Perioperative considerations for evolving artificial pancreas devices. Anesth Analg 128:902\u2013906. https:\/\/doi.org\/10.1213\/ANE.0000000000003779","journal-title":"Anesth Analg"},{"key":"6838_CR74","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.2337\/dc22-0438","volume":"45","author":"D Herzig","year":"2022","unstructured":"Herzig D, Suhner S, Roos J et al (2022) Perioperative fully closed-loop insulin delivery in patients undergoing elective surgery: an open-label, randomized controlled trial. Diabetes Care 45:2076\u20132083. https:\/\/doi.org\/10.2337\/dc22-0438","journal-title":"Diabetes Care"},{"key":"6838_CR75","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1177\/1932296820932903","volume":"14","author":"RJ Galindo","year":"2020","unstructured":"Galindo RJ, Aleppo G, Klonoff DC et al (2020) Implementation of continuous glucose monitoring in the hospital- emergent considerations for remote glucose monitoring during the COVID-19 pandemic. J Diabetes Sci Technol 14:822\u2013832. https:\/\/doi.org\/10.1177\/1932296820932903","journal-title":"J Diabetes Sci Technol"},{"key":"6838_CR76","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/1932296817748964","volume":"12","author":"EK Spanakis","year":"2018","unstructured":"Spanakis EK, Levitt DL, Siddiqui T et al (2018) The effect of continuous glucose monitoring in preventing inpatient hypoglycemia in general wards: the glucose telemetry system. J Diabetes Sci Technol 12:20\u201325. https:\/\/doi.org\/10.1177\/1932296817748964","journal-title":"J Diabetes Sci Technol"},{"key":"6838_CR77","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1177\/1932296821994586","volume":"16","author":"C Dillmann","year":"2022","unstructured":"Dillmann C, Amoura L, Fall Mostaine F, Coste A, Bounyar L, Kessler L (2022) Feasibility of real-time continuous glucose monitoring telemetry system in an inpatient diabetes unit: a pilot study. J Diabetes Sci Technol 16:955\u2013961. https:\/\/doi.org\/10.1177\/1932296821994586","journal-title":"J Diabetes Sci Technol"},{"key":"6838_CR78","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.4158\/EP161392.CS","volume":"22","author":"VA Fonseca","year":"2016","unstructured":"Fonseca VA, Grunberger G, Anhalt H et al (2016) Continuous glucose monitoring: a consensus Conference of the American Association of Clinical Endocrinologists and American College of Endocrinology. Endocr Pract 22:1008\u20131021. https:\/\/doi.org\/10.4158\/EP161392.CS","journal-title":"Endocr Pract"},{"key":"6838_CR79","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.eprac.2023.06.007","volume":"29","author":"V Bellido","year":"2023","unstructured":"Bellido V, Freckman G, P\u00e9rez A, Galindo RJ (2023) Accuracy and potential interferences of continuous glucose monitoring sensors in the hospital. Endocr Pract 29:919\u2013927. https:\/\/doi.org\/10.1016\/j.eprac.2023.06.007","journal-title":"Endocr Pract"},{"key":"6838_CR80","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.2337\/dc20-2856","volume":"44","author":"GM Davis","year":"2021","unstructured":"Davis GM, Spanakis EK, Migdal AL et al (2021) Accuracy of dexcom G6 continuous glucose monitoring in non-critically ill hospitalized patients with diabetes. Diabetes Care 44:1641\u20131646. https:\/\/doi.org\/10.2337\/dc20-2856","journal-title":"Diabetes Care"},{"key":"6838_CR81","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.2337\/dc20-2386","volume":"44","author":"MC Perez-Guzman","year":"2021","unstructured":"Perez-Guzman MC, Duggan E, Gibanica S et al (2021) Continuous glucose monitoring in the operating room and cardiac intensive care unit. Diabetes Care 44:e50\u2013e52. https:\/\/doi.org\/10.2337\/dc20-2386","journal-title":"Diabetes Care"},{"key":"6838_CR82","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1177\/1932296818812062","volume":"13","author":"G Freckmann","year":"2019","unstructured":"Freckmann G, Pleus S, Grady M, Setford S, Levy B (2019) Measures of accuracy for continuous glucose monitoring and blood glucose monitoring devices. J Diabetes Sci Technol 13:575\u2013583. https:\/\/doi.org\/10.1177\/1932296818812062","journal-title":"J Diabetes Sci Technol"},{"key":"6838_CR83","doi-asserted-by":"publisher","unstructured":"Avari P, Choudhary P, Lumb A et al (2025) Using technology to support diabetes care in hospital: guidelines from the Joint British Diabetes Societies for Inpatient Care (JBDS\u2010IP) group and Diabetes Technology Network (DTN) UK. Diabet Med 42. https:\/\/doi.org\/10.1111\/dme.15452","DOI":"10.1111\/dme.15452"},{"key":"6838_CR84","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1007\/s00125-024-06250-0","volume":"67","author":"MY O\u2019Connor","year":"2024","unstructured":"O\u2019Connor MY, Flint KL, Sabean A et al (2024) Accuracy of continuous glucose monitoring in the hospital setting: an observational study. Diabetologia 67:2650\u20132659. https:\/\/doi.org\/10.1007\/s00125-024-06250-0","journal-title":"Diabetologia"},{"key":"6838_CR85","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1177\/19322968221138299","volume":"17","author":"D Flanagan","year":"2023","unstructured":"Flanagan D, Avari P, Choudhary P et al (2023) Using technology to improve diabetes care in hospital: the challenge and the opportunity. J Diabetes Sci Technol 17:503\u2013508. https:\/\/doi.org\/10.1177\/19322968221138299","journal-title":"J Diabetes Sci Technol"},{"key":"6838_CR86","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1177\/19322968221093662","volume":"16","author":"NY Xu","year":"2022","unstructured":"Xu NY, Nguyen KT, DuBord AY et al (2022) The launch of the iCoDE standard project. J Diabetes Sci Technol 16:887\u2013895. https:\/\/doi.org\/10.1177\/19322968221093662","journal-title":"J Diabetes Sci Technol"},{"key":"6838_CR87","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1177\/19322968231207888","volume":"18","author":"RE Aaron","year":"2024","unstructured":"Aaron RE, Tian T, Yeung AM, Huang J, Klonoff DC, Espinoza JC (2024) The launch of the iCoDE-2 standard project: integration of connected diabetes device data into the electronic health record. J Diabetes Sci Technol 18:82\u201388. https:\/\/doi.org\/10.1177\/19322968231207888","journal-title":"J Diabetes Sci Technol"},{"key":"6838_CR88","unstructured":"Espinoza J, Klonoff D, Carini S (2025) 2025 iCoDE Report: EHR integration standards and recommendations for insulin delivery data. Available from: https:\/\/diabetestechnology.org\/icode2. Accessed 12 Jan 2026"},{"key":"6838_CR89","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1177\/19322968241264761","volume":"19","author":"C Selmer","year":"2025","unstructured":"Selmer C, Green A, Madsen S, Johannesen M, Jensen MT, N\u00f8rgaard K (2025) Stenopool: a comprehensive platform for consolidating diabetes device data. J Diabetes Sci Technol 19:1486\u20131495. https:\/\/doi.org\/10.1177\/19322968241264761","journal-title":"J Diabetes Sci Technol"},{"key":"6838_CR90","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1177\/19322968221106206","volume":"17","author":"W Matievich","year":"2023","unstructured":"Matievich W, Kiaie N, Dunn TC (2023) Safety and functional integrity of continuous glucose monitoring sensors when used during radiologic procedures under high exposure conditions. J Diabetes Sci Technol 17:1634\u20131643. https:\/\/doi.org\/10.1177\/19322968221106206","journal-title":"J Diabetes Sci Technol"},{"key":"6838_CR91","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1177\/1932296820930038","volume":"14","author":"AL Migdal","year":"2020","unstructured":"Migdal AL, Spanakis EK, Galindo RJ et al (2020) Accuracy and precision of continuous glucose monitoring in hospitalized patients undergoing radiology procedures. J Diabetes Sci Technol 14:1135\u20131136. https:\/\/doi.org\/10.1177\/1932296820930038","journal-title":"J Diabetes Sci Technol"},{"key":"6838_CR92","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1177\/1932296820920948","volume":"15","author":"C Thomas","year":"2021","unstructured":"Thomas C, Welsh JB, Lu S, Gray JM (2021) Safety and functional integrity of continuous glucose monitoring components after simulated radiologic procedures. J Diabetes Sci Technol 15:781\u2013785. https:\/\/doi.org\/10.1177\/1932296820920948","journal-title":"J Diabetes Sci Technol"},{"key":"6838_CR93","doi-asserted-by":"publisher","first-page":"2210509","DOI":"10.1155\/2024\/2210509","volume":"2024","author":"S Tellez","year":"2024","unstructured":"Tellez S, Hornung L, Smith E et al (2024) Real-world accuracy of a continuous glucose monitoring system after radiologic exposure. Pediatr Diabetes 2024:2210509. https:\/\/doi.org\/10.1155\/2024\/2210509","journal-title":"Pediatr Diabetes"},{"key":"6838_CR94","unstructured":"US Food and Drug Administration (2024) Preventing damage to wearable diabetes devices during imaging and radiation procedures. Available from: https:\/\/www.fda.gov\/radiation-emitting-products\/electronic-medical-devices-x-ray-imaging-and-radiation-therapy-what-know-and-how-prevent-damage\/preventing-damage-wearable-diabetes-devices-during-imaging-and-radiation-procedures. Accessed 24 Mar 2025"},{"key":"6838_CR95","unstructured":"Abbott (2024) Abbott\u2019s FreeStyle Libre\u00ae 2 and 3: first continuous glucose monitoring systems approved for use during medical imaging. Available from: https:\/\/abbott.mediaroom.com\/press-releases?item=124675. 2024. https:\/\/abbott.mediaroom.com\/press-releases?item=124675. Accessed 8 Mar 2025"},{"key":"6838_CR96","unstructured":"Abbott (2024) Can you wear a CGM during an MRI? If it\u2019s ours, you can. Available from: https:\/\/www.abbott.com\/corpnewsroom\/diabetes-care\/can-you-wear-a-cgm-during-an-mri--if-its-ours-you-can.html. Accessed 28 March"},{"key":"6838_CR97","unstructured":"Eversense (2019) Senseonics Eversense CGM sensor receives indication for MRI. Available from: https:\/\/www.senseonics.com\/investor-relations\/news-releases\/2019\/01-30-2019-002321416. Accessed 29 April 2025"},{"key":"6838_CR98","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1177\/19322968241260038","volume":"19","author":"D Lazar","year":"2025","unstructured":"Lazar D, Tao M, Matievich W, Kastanos K, Dunn TC (2025) Accuracy and functionality of select continuous glucose monitoring systems are not impacted by implantable cardioverter defibrillator devices. J Diabetes Sci Technol 19:1385\u20131391. https:\/\/doi.org\/10.1177\/19322968241260038","journal-title":"J Diabetes Sci Technol"},{"key":"6838_CR99","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.2337\/dc14-0479","volume":"37","author":"GE Umpierrez","year":"2014","unstructured":"Umpierrez GE, Reyes D, Smiley D et al (2014) Hospital discharge algorithm based on admission HbA1c for the management of patients with type 2 diabetes. Diabetes Care 37:2934\u20132939. https:\/\/doi.org\/10.2337\/dc14-0479","journal-title":"Diabetes Care"},{"key":"6838_CR100","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1177\/19322968231200847","volume":"18","author":"T Tian","year":"2024","unstructured":"Tian T, Aaron RE, Seley JJ et al (2024) Use of continuous glucose monitors upon hospital discharge of people with diabetes: promise, barriers, and opportunity. J Diabetes Sci Technol 18:207\u2013214. https:\/\/doi.org\/10.1177\/19322968231200847","journal-title":"J Diabetes Sci Technol"},{"key":"6838_CR101","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.eprac.2024.11.018","volume":"31","author":"GE Umpierrez","year":"2025","unstructured":"Umpierrez GE, Castro-Revoredo I, Moazzami B et al (2025) Randomized study comparing continuous glucose monitoring and capillary glucose testing in patients with type 2 diabetes after hospital discharge. Endocr Pract 31:286\u2013291. https:\/\/doi.org\/10.1016\/j.eprac.2024.11.018","journal-title":"Endocr Pract"},{"key":"6838_CR102","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1177\/19322968251332656","volume":"19","author":"S Kantipudi","year":"2025","unstructured":"Kantipudi S, Idrees T, Castro-Revoredo I et al (2025) Assessment of glycemic control using continuous glucose monitoring during hospitalization and after discharge for older adults. J Diabetes Sci Technol 19:1427\u20131428. https:\/\/doi.org\/10.1177\/19322968251332656","journal-title":"J Diabetes Sci Technol"},{"key":"6838_CR103","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000521288","volume":"91","author":"ME Charlson","year":"2022","unstructured":"Charlson ME, Carrozzino D, Guidi J, Patierno C (2022) Charlson comorbidity index: a critical review of clinimetric properties. Psychother Psychosom 91:8\u201335. https:\/\/doi.org\/10.1159\/000521288","journal-title":"Psychother Psychosom"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-026-06838-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-026-06838-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-026-06838-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:53:30Z","timestamp":1793109210000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-026-06838-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":103,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["6838"],"URL":"https:\/\/doi.org\/10.1007\/s00125-026-06838-8","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"assertion":[{"value":"22 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors are deeply grateful for the valuable insights provided by the patient advisory council during the development of this position statement. The following members consented to be acknowledged by name: Kirsten Jorsal (Denmark), Marcel Tamegger (Austria), Loida Nedeltsou (Greece), Freek den Dulk (the Netherlands) and Pilar Gimeno (Spain).","order":1,"name":"Ethics","label":"Acknowledgements","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"No new data were created or analysed in this article. All data supporting the findings of this consensus report are available within the article and its electronic supplementary material, or from the references cited within the article.","order":2,"name":"Ethics","label":"Data availability","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This report received no specific grant from any funding agency in the public, commercial or not-for-profit sectors. No sponsor\/funder was involved in the design of the study, the collection, analysis and interpretation of data, or writing the report, and there were no restrictions regarding the publication of the report.","order":3,"name":"Ethics","label":"Funding","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"MTO serves on the scientific advisory board for decide Clinical Software (GlucoTab). EKS has received research support from Dexcom, Medtronic, Sequel Med Tech and Tandem Diabetes Care for the conduct of clinical trials. HT has received research support from Dexcom and participated in advisory groups for Dexcom, Medtronic, Sanofi and Roche Diabetes. KDh has received honoraria, travel support or fees for speaking or advisory board meetings from Abbott Diabetes, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Menarini, Novo Nordisk, Roche and Sanofi Diabetes. PA has received research support from Dexcom. ANL has received research support from Abbott and Novo Nordisk and has received speakers fees and payment for attending advisory boards from Abbot, Dexcom, Insulet, Lilly Diabetes, Medtronic, Menarini, Novo Nordisk, Roche and Sanofi. He is Chair of Diabetes Technology Network-UK (DTN-UK) (details of external support to DTN-UK available from\n                      \n                      ). KDu has received research support from Dexcom, Abbott, Insulet and UpToDate and serves on the advisory board for Eli Lilly. AP-T has received research support from and serves on the advisory boards for Dexcom, Medtronic, Eli Lilly, Novo Nordisk and Concept and serves on the advisory board for Regeneron. DNO has received research support from and serves on the advisory boards for Medtronic, Insulet, Roche and Abbott. SRJ has received speaker fees from Abbott, Novo Nordisk and Sanofi. ALL has received speaker fees and\/or support to attend conferences from Dexcom and Novo Nordisk and research support from the Association of British Clinical Diabetologists. EGW has received personal fees from Abbott, AstraZeneca, Dexcom, Eli Lilly, embecta, Insulet, Medtronic, Novo Nordisk, Roche, Sanofi, Sinocare and Ypsomed and research support from Abbott, embecta, Insulet, Novo Nordisk and Sanofi. JLVS has received research support from Roche. RV has served on advisory panels for Abbott, Boehringer Ingelheim, Dexcom, Eli Lilly, Medtronic, Novo Nordisk, Roche and Sanofi (fees paid to the institution KU Leuven). CM serves or has served on advisory panels for Abbott, Bayer, Biomea Fusion, Boehringer Ingelheim, Eli Lilly, Insulet, Medtronic, Novartis, Novo Nordisk, Roche, SAb Biotherapeutics, Sanofi and Vertex Pharmaceuticals (financial compensation paid to institution); has received research support (to institution) from ActoBio Therapeutics, Medtronic, Novo Nordisk and Sanofi; serves or has served on speaker bureaus for Abbott, Dexcom, Eli Lilly, Medtronic, Novo Nordisk, Roche, Sanofi and Vertex Pharmaceuticals (financial compensation paid to institution); and was President of EASD from 2022 to 2025 (information on all external support from EASD is available from\n                      \n                      ) and Vice-President of the European Diabetes Forum from 2023 to 2025. IBH reports research support from Dexcom, Tandem Diabetes Care and MannKind and consulting fees from Abbott Diabetes Care, Roche, embecta and Vertex Pharmaceuticals. FJP has received research support through his institution from Dexcom, Tandem Diabetes Care, Insulet, Novo Nordisk and Ideal Medical Technologies and personal consulting fees from Dexcom and has provided consulting services for Insulet (services paid to his institution). FJP is an editor of\n                      Diabetes Care\n                      but was not involved in any of the decisions regarding review of the manuscript or its acceptance. GU has received research support (to Emory University) from Abbott, Dexcom, Corcept Therapeutics and Bayer and has served as a member of advisory boards for Dexcom, Glucotrack and GlyCare. RJG has received research support from Novo Nordisk, Boehringer Ingelheim, Roche, twiist\/DEKA and Dexcom and served on the advisory board or as a consultant for Amgen, Bayer, Boehringer, Eli Lilly, Gan & Lee Pharmaceuticals, Dexcom, Medtronic and Novo Nordisk. UP-B has received speakers fees from Abbott, Sanofi and Novo Nordisk and has served on advisory boards for Sanofi and Novo Nordisk. UP-B is a member of the editorial board of\n                      Diabetologia\n                      . JKM reports serving as a member of advisory boards of Abbott Diabetes Care, Becton, Dickinson and Company, Dexcom, Eli Lilly, embecta, Insulet, Medtronic, Novo Nordisk, PharmaSens, Roche Diabetes Care, Sanofi, Tandem Diabetes Care and Viatris. She has received speaker honoraria from A. Menarini Diagnostics, Abbott Diabetes Care, BUZUD, Dexcom, Eli Lilly, MedTrust, Novo Nordisk, Roche Diabetes Care, Sanofi, Sinocare, Viatris and Ypsomed. She is a shareholder of decide Clinical Software and elyte diagnostics and serves as Chief Marketing Officer of elyte diagnostics. KN serves as an adviser to Medtronic, Abbott, Convatec and Novo Nordisk; owns shares in Novo Nordisk; has received research grants (to institution) from Novo Nordisk, Zealand Pharma, Dexcom and Medtronic; and has received fees for speaking from Medtronic and Novo Nordisk. No other potential conflicts of interest relevant to this article were reported. Some authors disclosed conflicts of interest as listed above, which were fully declared and addressed during the consensus process via forming balanced subgroups. Drafts were reviewed and critically discussed by the full panel\u2014including members with no conflicts and those with offsetting interests\u2014to ensure diverse perspectives. Additionally, an advisory council of individuals living with diabetes provided independent input to help ensure that the recommendations reflect broad stakeholder views.","order":4,"name":"Ethics","label":"Authors\u2019 relationships and activities","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"MTO, KN, JKM, PLK and UP-B initially created a compendium of topic areas for consideration by the rest of the expert panel. Authors were primarily responsible for developing the nine subtopics as follows: PA, KDh, UP-B and GU, subtopic 1; KDu, AP-T, EKS and KN, subtopic 2; MTO, HT and RJG, subtopic 3; FJP and JKM, subtopic 4; JLVS, PV and PLK, subtopic 5; KK and RV, subtopic 6; ANL, SRJ and IBH, subtopic 7; DNO, CM and OGM, subtopic 8; and EGW and ALL, subtopic 9. A consolidated draft consensus manuscript and consensus recommendations were developed by all authors. The draft was then revised by all authors. The final draft was approved by all authors.","order":5,"name":"Ethics","label":"Contribution statement","group":{"name":"EthicsHeading","label":"Ethics"}}]}}